United Therapeutics reported $409.3M in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Alexion Pharmaceuticals ALXN:US $ 1511.1M 71.5M
Amarin AMRN:US $ 122.33M 8.49M
Ardelyx ARDX:US $ 1.31M 4.27M
Baxter International BAX:US $ 1242M 77M
Bayer BAYN:GR 6.31B 1.32B
Biocryst Pharmaceuticals BCRX:US $ 49.62M 36.44M
Biogen BIIB:US $ 2267.1M 48.2M
Biomarin Pharmaceutical BMRN:US $ 374.63M 8.77M
Emergent Biosolutions EBS:US $ 169.7M 74M
Esperion Therapeutics ESPR:US $ 38.86M 32.66M
Gilead Sciences GILD:US $ 4827M 235M
GlaxoSmithKline GSK:LN 5.57B 566M
Halozyme Therapeutics HALO:US $ 113.44M 42.63M
Insmed INSM:US $ 34.53M 4.16M
Intercept Pharmaceuticals ICPT:US $ 95.96M 15.11M
Intra Cellular Therapies ITCI:US $ 18.01M 3.58M
Johnson & Johnson JNJ:US $ 16088M 343M
Lexicon Pharmaceuticals LXRX:US 234K 207K
Moderna Inc MRNA:US 3.6B 1.86B
Omeros OMER:US $ 28.48M 7.68M
Pfizer PFE:US $ 11985M 1575M
Ptc Therapeutics PTCT:US $ 109.32M 0.48M
Regeneron Pharmaceuticals REGN:US $ 4444.8M 2224.1M
Sarepta Therapeutics SRPT:US $ 144.57M 19.99M
Seattle Genetics SGEN:US $ 310.39M 42.54M
Teva Pharmaceutical TEVA:IT 1.92B 4M
United Therapeutics UTHR:US $ 409.3M 53.2M
Vertex Pharmaceuticals VRTX:US $ 1565.4M 33.42M